WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Osteoporosis Efficacy Criteria v4, Concepts proposed for removal from CMAP are denoted by grey color boxes, FDA Efficacy Criteria for Osteoporosis include major covariates Concomitant Medications, Concomitant Medications instantiated_by Concomitant Medications, Vertebral height has units mm, FDA Efficacy Criteria for Osteoporosis include The proportion of patients with fracture, FDA Efficacy Criteria for Osteoporosis include major covariates Number of normal vertebral bodies at risk, Blood for serum biomarkers, Radiographic Test performed at Time points, Vertebral fracture manifest_as asymptomatic, Biochemical markers of bone turnover obtained from testing Urine, Radiographic Test classified by Quantitative Morphometry, T-score measured in units Standard Deviations (SD), Concepts are denoted by solid round-edged rectangle, Anatomical Locations instantiated_by Anatomical Locations, Bone Mineral Density (BMD) ???? Time Points, Vertebral height instantiated_by vertebral height, symptomatic refers_to Clinical Fracture, Semi-Quantitative Assessment assesses Vertebral shape, Vertebral shape instantiated by vertebral shapes, asymptomatic diagnosed with Radiographic Test